Document is current
Any future updates will be listed below
-
Authors
Su, Kaisheng
Qi, Tuan
He, Jiangping
Zhang, Xiaofang
Liu, Lei
Zhou, Yanzi
Gu, Jueqing
Yi, Caihong
Wang, Jundi
Wang, Limin
Wang, Jiaoli
Xia, Junbo
Jin, Xuedi
Chang, Xing
Zhang, Chu
Zhang, Fengchun
Huang, Jiao
-
Funding
Funding for this research was provided by:
Zhejiang Province health industry science and technology plan project (2025HY0664)
the Construction Fund of Key Medical Disciplines of Hangzhou (Immune Disease and Precision Medicine,2025HZGF01)
Zhejiang Clinical innovation Pride (CXTD202502001)
- License Information
-
More Information
Article History
Received: 26 February 2026
Accepted: 7 May 2026
First Online: 12 May 2026
Declarations
:
: This study was specifically reviewed and approved by the Westlake University School of Medicine affiliated First People’s Hospital of Hangzhou in compliance with the Declaration of Helsinki (approval number: ZN-2024400-01). Patients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of our research.
: The authors declare no competing interests.
: All authors gave final approval of this version to be published, and are accountable for all aspects of the work in ensuring accuracy and integrity.
